A public information campaign “to enlighten patients about biologic medicines and to encourage the prescription of biosimilars” has been launched by Belgian medicines agency AFMPS, in conjunction with local health insurer INAMI.
Explaining that the campaign was aimed at “informing patients about biologic medicines, which widen the field of possibilities for treating...





